Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status

Forbes, (2011), COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res., 39, D945, 10.1093/nar/gkq929

Børresen-Dale, (2003), TP53 and breast cancer, Hum. Mutat., 21, 292, 10.1002/humu.10174

Koboldt,D.C. et al. (2012) Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412

Carey, (2006), Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA, 295, 2492, 10.1001/jama.295.21.2492

Troester, (2006), Gene expression patterns associated with p53 status in breast cancer, BMC Cancer, 6, 276, 10.1186/1471-2407-6-276

Sørlie, (2001), Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl Acad. Sci. USA, 98, 10869, 10.1073/pnas.191367098

Langerød, (2007), TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer, Breast Cancer Res., 9, R30, 10.1186/bcr1675

Dumay, (2013), Distinct tumor protein p53 mutants in breast cancer subgroups, Int. J. Cancer, 132, 1227, 10.1002/ijc.27767

Olivier, (2006), The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer, Clin. Cancer Res., 12, 1157, 10.1158/1078-0432.CCR-05-1029

Troester, (2004), Cell-type-specific responses to chemotherapeutics in breast cancer, Cancer Res., 64, 4218, 10.1158/0008-5472.CAN-04-0107

Suzuki, (2009), Modulation of microRNA processing by p53, Nature, 460, 529, 10.1038/nature08199

Bartel, (2004), MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Miska, (2005), How microRNAs control cell division, differentiation and death, Curr. Opin. Genet. Dev., 15, 563, 10.1016/j.gde.2005.08.005

Iorio, (2005), MicroRNA gene expression deregulation in human breast cancer, Cancer Res., 65, 7065, 10.1158/0008-5472.CAN-05-1783

Chang, (2007), Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis, Mol. Cell, 26, 745, 10.1016/j.molcel.2007.05.010

Corney, (2007), MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth, Cancer Res., 67, 8433, 10.1158/0008-5472.CAN-07-1585

Sachdeva, (2009), p53 represses c-Myc through induction of the tumor suppressor miR-145, Proc. Natl Acad. Sci. USA, 106, 3207, 10.1073/pnas.0808042106

Yamakuchi, (2010), P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis, Proc. Natl Acad. Sci. USA, 107, 6334, 10.1073/pnas.0911082107

Georges, (2008), Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215, Cancer Res., 68, 10105, 10.1158/0008-5472.CAN-08-1846

Hu, (2010), Negative regulation of tumor suppressor p53 by microRNA miR-504, Mol. Cell, 38, 689, 10.1016/j.molcel.2010.05.027

Le, (2009), MicroRNA-125b is a novel negative regulator of p53, Genes Dev., 23, 862, 10.1101/gad.1767609

Park, (2009), miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42, Nat. Struct. Mol. Biol., 16, 23, 10.1038/nsmb.1533

Yamakuchi, (2008), miR-34a repression of SIRT1 regulates apoptosis, Proc. Natl Acad. Sci. USA, 105, 13421, 10.1073/pnas.0801613105

Fornari, (2009), MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells, Cancer Res., 69, 5761, 10.1158/0008-5472.CAN-08-4797

Ghose, (2011), Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington’s disease, PLoS One, 6, e23837, 10.1371/journal.pone.0023837

Blenkiron, (2007), MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype, Genome Biol., 8, R214, 10.1186/gb-2007-8-10-r214

Abboud, (2007), Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells, Int. J. Oncol., 30, 113

Kucharczak, (2003), To be, or not to be: NF-kappaB is the answer–role of Rel/NF-kappaB in the regulation of apoptosis, Oncogene, 22, 8961, 10.1038/sj.onc.1207230

Bhaumik, (2008), Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells, Oncogene, 27, 5643, 10.1038/onc.2008.171

Taganov, (2006), NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl Acad. Sci. USA, 103, 12481, 10.1073/pnas.0605298103

Ikner, (2011), TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8, J. Biol. Chem., 286, 21546, 10.1074/jbc.M110.203745

Hollstein, (1994), Database of p53 gene somatic mutations in human tumors and cell lines, Nucleic Acids Res., 22, 3551

Soussi, (2005), Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations, Hum. Mutat., 25, 6, 10.1002/humu.20114

Carey, (2007), The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes, Clin. Cancer Res., 13, 2329, 10.1158/1078-0432.CCR-06-1109

Sorlie, (2003), Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc. Natl Acad. Sci. USA, 100, 8418, 10.1073/pnas.0932692100

Mouchawar, (2010), Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study, Cancer Res., 70, 4795, 10.1158/0008-5472.CAN-09-0851

Ponomarev, (2013), MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS, Glia, 61, 91, 10.1002/glia.22363

Perkins, (2006), Good cop, bad cop: the different faces of NF-kappaB, Cell Death Differ., 13, 759, 10.1038/sj.cdd.4401838

Dvinge, (2013), The shaping and functional consequences of the microRNA landscape in breast cancer, Nature, 497, 378, 10.1038/nature12108

Liu, (2009), MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis, Biochem. Biophys. Res. Commun., 380, 177, 10.1016/j.bbrc.2009.01.066

Shen, (2008), A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis, Carcinogenesis, 29, 1963, 10.1093/carcin/bgn172

Garcia, (2011), Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers, EMBO Mol. Med., 3, 279, 10.1002/emmm.201100136

Elstrodt, (2006), BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants, Cancer Res., 66, 41, 10.1158/0008-5472.CAN-05-2853

Luo, (2013), A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells, J. Transl. Med., 11, 57, 10.1186/1479-5876-11-57

Wang, (2008), Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth, PLoS One, 3, e2557, 10.1371/journal.pone.0002557

Pacifico, (2010), Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a, J. Clin. Endocrinol. Metab., 95, 1421, 10.1210/jc.2009-1128

Li, (2010), miR-146a suppresses invasion of pancreatic cancer cells, Cancer Res., 70, 1486, 10.1158/0008-5472.CAN-09-2792

Yao, (2013), MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2, Cancer Lett, 335, 219, 10.1016/j.canlet.2013.02.031

Khoury, (2011), p53 isoforms: an intracellular microprocessor?, Genes Cancer, 2, 453, 10.1177/1947601911408893

Soussi, (2001), Assessing TP53 status in human tumours to evaluate clinical outcome, Nat. Rev. Cancer, 1, 233, 10.1038/35106009